Home>>Sci-Edu
Last updated at: (Beijing Time) Tuesday, April 22, 2003

Shanghai Scientists Dedicated to Seeking Cure for SARS

A senior scientist based in Shanghai Monday said the Shanghai Academy of Life Sciences of the Chinese Academy of Sciences (CAS) was developing a cure for severeacute respiratory syndrome (SARS).


PRINT DISCUSSION CHINESE SEND TO FRIEND


A senior scientist based in Shanghai Monday said the Shanghai Academy of Life Sciences of the Chinese Academy of Sciences (CAS) was developing a cure for severeacute respiratory syndrome (SARS).

Pei Gang, a CAS academician and president of the Shanghai academy, said his academy had set up a special team dedicated to research the diagnosis and treatment of the disease.

He made the remarks at Monday's conference marking the 50th anniversary of the discovery of the double helix structure of DNA by James Watson, an American, and Francis Crick, a British biophysicist. They shared the Nobel Prize for the work.

He said the research would help pinpoint the cause of the disease, variations of the virus and the immune process after being infected.

Successful research had already showed ways to stop the expression of SARS virus protein, he said, adding that the research on immunological treatment would help find an effective antibody to cure the disease.

He said his academy was trying to find an effective medicine from existing antivirus treatments and meanwhile develop a new cure.


Questions?Comments? Click here
    Advanced






Chinese Scientists Confront the SARS Challenge

Shanghai Vows to Sincerely Cooperate with WHO

Second SARS Patient Found in Shanghai





>> Full Coverage

 


No Staff of Iraqi Embassy in China Seeking Asylum ( 3 Messages)

Change of DPRK's Attitude Attracts Attention ( 3 Messages)

Beijing Takes Innovative Measures to Control SARS: WHO Expert ( 4 Messages)

China Sees 9.9 Percent GDP Growth in First Quarter ( 5 Messages)

Seize Opportunities to Speed up Development: President ( 3 Messages)



Copyright by People's Daily Online, all rights reserved